Showing results (51-60 of 61) with videos related to
Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2009
Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaquesRobert M Koffie, Melanie Meyer-Luehmann, Tadafumi Hashimoto, et al.The Journal of Clinical Investigation|June 21, 2016
RBPJ maintains brain tumor-initiating cells through CDK9-mediated transcriptional elongationQi Xie, Qiulian Wu, Leo Kim, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 16, 2013
A dramatic increase of C1q protein in the CNS during normal agingAlexander H Stephan, Daniel V Madison, José María Mateos, et al.Cancer Discovery|December 18, 2020
A Critical Role for Fas-Mediated Off-Target Tumor Killing in T-cell ImmunotherapyRanjan Upadhyay, Jonathan A Boiarsky, Gvantsa Pantsulaia, et al.Journal of Vitreoretinal Diseases|June 2, 2025
Clinical Characteristics, Outcomes, and Complications Associated With Delayed Diagnosis of Intraocular Foreign BodyMelissa Yuan, Lindsay K Kozek, Sandra Hoyek, et al.The British Journal of Ophthalmology|May 14, 2026
Multimodal imaging determinants of contrast sensitivity loss in geographic atrophyFrancesco Romano, Isabella Stettler, Matthew Finn, et al.The British Journal of Ophthalmology|May 13, 2025
Choriocapillaris impairment in dry AMD: insights from swept-source OCT angiography and associations with structural biomarkersKatherine Overbey, Francesco Romano, Xinyi Ding, et al.Biorxiv : the Preprint Server for Biology|October 3, 2025
Potentiating CAR-T bystander killing by enhanced Fas/FasL signaling mitigates antigen escape in heterogeneous tumorsMatthew J Lin, Joanna K Chorazeczewski, Gvantsa Pantsulaia, et al.The British Journal of Ophthalmology|September 14, 2025
Correlation between quantitative OCT metrics and contrast sensitivity function in retinal artery occlusionChong Chen, Rajiv M Sastry, Leiyu Wang, et al.Science Translational Medicine|June 1, 2018
Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistanceYu Shi, Olga A Guryanova, Wenchao Zhou, et al.Pageof 7